Community pharmacy services for drug misuse: Attitudes and practices of Finnish pharmacists

International Journal of Drug Policy

Volumn 25, Issue 6, 2014, Pages 1139-1142

  Uosukainen, Hanna ^a   Turunen, Juha H O ^b   Ilomäki, Jenni ^c   Bell, J Simon ^a,c,d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Farenta Oy   (Finland)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMMUNITY PHARMACY SERVICE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG MISUSE; EXPLORATORY RESEARCH; FINLAND; FINN (CITIZEN); HUMAN; PHARMACEUTICAL CARE; PHARMACIST ATTITUDE; PRESCRIPTION; PROFESSIONAL PRACTICE; PUBLIC HEALTH SERVICE; STRUCTURED QUESTIONNAIRE; SUBURBAN AREA; URBAN AREA; HEALTH PERSONNEL ATTITUDE; PHARMACIST; PHARMACY; PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS;

ATTITUDE OF HEALTH PERSONNEL; COMMUNITY PHARMACY SERVICES; FINLAND; HUMANS; PHARMACISTS; SUBSTANCE-RELATED DISORDERS;

EID: 84922410313     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2014.05.009     Document Type: Article

References (15)

1. Chaar B.B., Hanrahan J.R., Day E. Provision of opioid substitution therapy services in Australian pharmacies. Australasian Medical Journal 2011, 4:210-216.
2. Eades C.E., Ferguson J.S., O'Carroll R.E. Public health in community pharmacy: A systematic review of pharmacist and consumer views. BMC Public Health 2011, 11:582.
3. Fleming G.F., McElnay J.C., Hughes C.M., Sheridan J., Strang J. The role of the community pharmacist in drug abuse: A comparison of service provision between Northern Ireland and England/Wales. Pharmacy World & Science 2001, 23:13-16.
4. Gjersing L., Waal H., Caplehorn J.R., Gossop M., Clausen T. Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment. BMC Health Services Research 2010, 10:194.
5. Lawrie T., Matheson C., Bond C.M., Roberts K. Pharmacy customers' views and experiences of using pharmacies which provide drug misuse services. Drug and Alcohol Review 2004, 23:195-202.
6. Lawrinson P., Roche A., Terao H., Le P.P. Dispensing opioid substitution treatment: Practices, attitudes and intentions of community-based pharmacists. Drug and Alcohol Review 2008, 27:47-53.
7. Lea T., Sheridan J., Winstock A. Consumer satisfaction with opioid treatment services at community pharmacies in Australia. Pharmacy World & Science 2008, 30:940-946.
8. Lutnick A., Case P., Kral A.H. Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings. Journal of Urban Health 2012, 89:354-364.
9. Matheson C., Bond C.M. Motivations for and barriers to community pharmacy services for drug misusers. International Journal of Pharmacy Practice 1999, 7:256-263.
10. Matheson C., Bond C.M., Tinelli M. Community pharmacy harm reduction services for drug misusers: National service delivery and professional attitude development over a decade in Scotland. Journal of Public Health 2007, 29:350-357.
11. McCormick R., Bryant L., Sheridan J., Gonzalez J. New Zealand community pharmacist attitudes toward opioid-dependent clients. Drugs: Education Prevention and Policy 2006, 13:563-575.
12. Samitca S., Huissoud T., Jeannin A., Dubois-Arber F. The role of pharmacies in the care of drug users: What has changed in ten years. The case of a Swiss region. European Addiction Research 2007, 13:50-56.
13. Sheridan J., Manning V., Ridge G., Mayet S., Strang J. Community pharmacies and the provision of opioid substitution services for drug misusers: Changes in activity and attitudes of community pharmacists across England 1995-2005. Addiction 2007, 102:1824-1830.
14. Sheridan J., Wheeler A., Walters C. Health problems and help-seeking activities of methadone maintenance clients at Auckland Methadone Service (AMS): Potential for community pharmacy service expansion?. Harm Reduction Journal 2005, 2:25.
15. Uosukainen H., Bell J.S., Laitinen K., Tacke U., Ilomäki J., Turunen J.H. First insights into community pharmacy based buprenorphine-naloxone dispensing in Finland. International Journal of Drug Policy 2013, 24:492-497.